Background illustration for clinical trials search

Paid Clinical Trials Fort Collins

Discover 1,271 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

for
Cystic Fibrosis
Location: Denver CO, Los Angeles CA
Sponsor: SpliSense Ltd.

Sex: All

Age: 18+

Code: NCT06429176

Phase2, Recruiting
Active & Responsive

Phase 2 Study to Assess the Safety and Efficacy of ANG003

for
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Location: Denver CO, Salt Lake City UT, Kansas City KS,
Sponsor: Anagram Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT07450547

Phase2, Recruiting
Active & Responsive

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Denver CO, Aurora CO, Kansas City KS, Dallas TX,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting
Active & Responsive

MoblO2 to Maintain Oxygenation

for
COPD (Chronic Obstructive Pulmonary Disease),
Location: Denver CO
Sponsor: Minnesota HealthSolutions

Sex: All

Age: 25 - 70+

Code: NCT07704567

Recruiting
Active & Responsive

Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD

for
Scleroderma
Location: Denver CO
Sponsor: National Jewish Health

Sex: All

Age: 21 - 70+

Code: NCT04535245

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Remote Sputum Collection in Cystic Fibrosis

for
Cystic Fibrosis, Infections
Location: Denver CO, Spokane WA, Baltimore MD, Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT06950892

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Aurora CO, Englewood CO, Colorado Springs CO, Topeka KS,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Aurora CO, Englewood CO, Colorado Springs CO,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Aurora CO, Westwood KS, Phoenix AZ, Maplewood MN,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

for
Systemic Lupus Erythematosus
Location: Aurora CO, Las Vegas NV, Columbus OH
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 65

Code: NCT06576271

Phase1, Recruiting
Active & Responsive

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Aurora CO, Centennial CO, Idaho Falls ID,
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 2 - 17

Code: NCT07221851

Phase3, Recruiting
Active & Responsive

DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

for
Perianal Fistula Due to Crohn's Disease
Location: Aurora CO, St Louis MO, Nashville TN, Philadelphia PA,
Sponsor: Direct Biologics, LLC

Sex: All

Age: 18 - 70+

Code: NCT06918808

Phase2, Recruiting
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Denver CO, Littleton CO, Salt Lake City UT,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting
Active & Responsive

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: Denver CO, Oklahoma City OK, Dallas TX, Austin TX,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT06999187

Phase1, Recruiting
Active & Responsive

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for
Healthy
Location: Aurora CO, Grand Island NE, Salt Lake City UT,
Sponsor: Pfizer

Sex: All

Age: 0 - 49

Code: NCT07160244

Phase3, Recruiting
Active & Responsive

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for
Obesity, Heart Failure
Location: Golden CO, Aurora CO, Amarillo TX, Lincoln NE,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07567001

Phase3, Recruiting
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Castle Rock CO, Ogden UT, Idaho Falls ID, Wichita KS,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase2, Phase3, Recruiting
Active & Responsive

Individualizing Treatment for Asthma in Primary Care (Full Study)

for
Asthma, Asthma Attack, Asthma Exacerbations
Location: Aurora CO, Houston TX, Charlotte NC, Chapel Hill NC,
Sponsor: DARTNet Institute

Sex: All

Age: 13 - 70+

Code: NCT07052942

Recruiting
Active & Responsive

Risk Factors in Early Multiple Sclerosis

for
Multiple Sclerosis, Magnetic Resonance Imaging, Biomarkers,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 30

Code: NCT03586986

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Aurora CO, Denver CO, Kansas City MO, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase3, Recruiting